Survival RateCell SurvivalDisease-Free SurvivalSurvivalSurvival AnalysisGraft SurvivalTreatment OutcomeKaplan-Meier EstimateRetrospective StudiesTime FactorsNeoplasm StagingProportional Hazards ModelsFollow-Up StudiesApoptosisAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyPrognosisNeoplasm Recurrence, LocalLung NeoplasmsMultivariate AnalysisBreast NeoplasmsAntineoplastic AgentsSignal TransductionTumor Markers, BiologicalImmunohistochemistryCell Line, TumorAdenocarcinomaNeoplasm MetastasisRisk FactorsProspective StudiesCohort StudiesChemotherapy, AdjuvantDisease ProgressionMice, Inbred C57BLCell ProliferationLiver NeoplasmsBrain NeoplasmsCells, CulturedCisplatinLymphatic MetastasisAge FactorsRegistriesCarcinoma, Non-Small-Cell LungFluorouracilTransplantation, HomologousPredictive Value of TestsRecurrenceDoxorubicinColorectal NeoplasmsCyclophosphamideCarcinoma, Squamous CellSurvival of Motor Neuron 1 ProteinGene Expression Regulation, NeoplasticMutationNeoplasmsGraft RejectionActuarial AnalysisMice, KnockoutDisease Models, AnimalDrug Administration ScheduleRisk AssessmentVincristineRadiotherapy, AdjuvantPancreatic NeoplasmsNeoplasm InvasivenessRemission InductionLife TablesMicrobial ViabilityLiver TransplantationKidney TransplantationGlioblastomaOvarian NeoplasmsCarcinoma, HepatocellularMelanomaReverse Transcriptase Polymerase Chain ReactionCarcinomaTissue SurvivalProto-Oncogene ProteinsMice, Inbred BALB CCell DeathSEER ProgramBlotting, WesternDose-Response Relationship, DrugRNA, MessengerMice, TransgenicStomach NeoplasmsCell LinePrednisonePhosphorylationGene Expression ProfilingAntibodies, MonoclonalCell DifferentiationPostoperative ComplicationsMultiple MyelomaProstatic NeoplasmsDeoxycytidineBone NeoplasmsPhosphatidylinositol 3-KinasesTissue DonorsNeoadjuvant Therapy